NuVasive

NuVasive® is a medical device company focused on developing minimally disruptive surgical products and procedurally integrated solutions for the spine. The Company is the third largest medical device company in the $8.2 billion global spine market. NuVasive’s principal product offering is based on its Maximum Access Surgery, or MAS® platform. The MAS platform combines several categories of solutions that collectively minimize soft tissue disruption during spine surgery with maximum visualization and safe, easy reproducibility for the surgeon: a proprietary software-driven nerve avoidance system and intra-operative monitoring support; MaXcess®, a unique split-blade retractor system; a wide variety of specialized implants; and several biologic products to aid in the spinal fusion process. MAS significantly reduces surgery time and returns patients to activities of daily living much faster than conventional approaches. Having redefined spine surgery with the MAS platform’s lateral approach, known as eXtreme Lateral Interbody Fusion, or XLIF®, NuVasive has built an entire spine franchise. With over 90 products today spanning lumbar, thoracic and cervical applications, the Company will continue to expand and evolve its offering predicated on its R&D focus and dedication to outstanding service levels supported by a culture of Absolute Responsiveness®.
Company Growth (employees)
Type
Public
HQ
San Diego, US
Founded
1997
Size (employees)
2,200 (est)
NuVasive was founded in 1997 and is headquartered in San Diego, US

NuVasive Office Locations

NuVasive has offices in San Diego, Memphis, Columbia, Fairborn and in 9 other locations
San Diego, US (HQ)
7475 Lusk Blvd
Amstelveen, NL
14 Grutterij
Milano, IT
32 Via Giacomo Watt
Chūō-ku, JP
銀座第13金井ビル
Elstree, GB
The Waterfront
Bremen, DE
75A Contrescarpe
Show all (13)

NuVasive Data and Metrics

NuVasive Financial Metrics

NuVasive's revenue was reported to be $249.9 m in Q1, 2017
USD

Revenue (Q1, 2017)

249.9 m

Gross profit (Q1, 2017)

188.3 m

Gross profit margin (Q1, 2017), %

75%

Net income (Q1, 2017)

12.3 m

Market capitalization (17-Aug-2017)

3.8 b

Cash (31-Mar-2017)

134 m
NuVasive's current market capitalization is $3.8 b.
USDFY, 2013Y, 2014Y, 2015FY, 2016

Revenue

685.2 m762.4 m811.1 m962.1 m

Revenue growth, %

11%6%19%

Cost of goods sold

180.5 m182.4 m194.5 m240.1 m

Gross profit

504.7 m580.1 m616.6 m722 m

Gross profit Margin, %

74%76%76%75%

R&D expense

48 m

Operating expense total

471.6 m561.9 m477.6 m598.5 m

EBIT

(13.6 m)

EBIT margin, %

(2%)

Interest expense

27.2 m27.9 m29.1 m40.5 m

Interest income

755 k968 k1.6 m1.1 m

Pre tax profit

9.8 m(11.2 m)112 m64.7 m

Income tax expense

2.8 m(6.3 m)(46.7 m)(29.3 m)

Net Income

7 m(17.5 m)65.3 m35.4 m
USDQ1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017

Revenue

192.4 m202.9 m200.5 m215 b236.2 m239.6 m249.9 m

Cost of goods sold

45.7 m48.4 m49.2 m54.2 b59.7 m59.2 m61.6 m

Gross profit

146.7 m154.5 m151.4 m160.8 b176.5 m180.5 m188.3 m

Gross profit Margin, %

76%76%75%75%75%75%75%

R&D expense

9.3 m8.8 m9.2 m10.6 b11.9 m12.5 m12.4 m

Operating expense total

9.3 m8.8 m9.2 m10.6 b11.9 m12.5 m12.4 m

Interest expense

(7.1 m)(7.2 m)(7.3 m)(8.5 b)(10.5 m)(11 m)(9.8 m)

Interest income

419 k344 k362 k328 m406 k190 k137 k

Pre tax profit

49.3 m18.7 m21.6 m(13.3 b)49.7 m10.5 m13.8 m

Income tax expense

(17.9 m)(8.6 m)(8.8 m)4 b(19.9 m)(7 m)(1.5 m)

Net Income

31.4 m41.4 m54.2 m(9.3 m)26 m29.5 m12.3 m
USDFY, 2013FY, 2014FY, 2015FY, 2016

Cash

102.8 m142.4 m192.3 m153.6 m

Inventories

10.9 m21.6 m8.8 m208.2 m

Current Assets

536 m705.9 m702.8 m575.4 m

PP&E

128.1 m128.6 m141.4 m181.5 m

Goodwill

154.9 m154.4 m154.3 m485.7 m

Total Assets

1.2 b1.3 b1.3 b1.6 b

Accounts Payable

77.6 m

Current Liabilities

117.2 m214.9 m99.6 m242.5 m

Additional Paid-in Capital

769.2 m847.1 m989.4 m1 b

Retained Earnings

(170.2 m)(186.9 m)(120.6 m)(66.9 m)

Total Equity

595.8 m648.4 m702.2 m700.5 m

Financial Leverage

2 x2.1 x1.8 x2.2 x
USDQ2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017

Cash

106.5 m130.7 m88.5 m78.6 m141.3 m270.1 m263.1 m203.8 m134 m

Inventories

157.4 m159.7 m163.4 m163.7 m164.9 m200.7 m201.9 m212.8 m223.1 m

Current Assets

587.1 m629.6 m632.9 m684.3 m698.5 m692.2 m712 m616.9 m563.3 m

PP&E

134.9 m131.2 m139.5 m142.1 m140.5 m153 m171.3 m179.9 m203.7 m

Goodwill

154.6 m154.5 m154.3 m154.3 m154.3 m404.3 m405.6 m498.7 m486.3 m

Total Assets

1.3 b1.3 b1.3 b1.3 b1.3 b1.6 b1.6 b1.6 b1.6 b

Accounts Payable

102.2 m108 m71.5 m61.1 m63.5 m77.4 m100.8 m72.6 m82.5 m

Current Liabilities

159.2 m169.2 m114 m132.4 m99.3 m128.1 m301.7 m280.4 m234.3 m

Additional Paid-in Capital

813.5 m822.9 m884.5 m940.8 m973.5 m961.2 m1 b1 b1 b

Retained Earnings

(192.6 m)(194.4 m)(155.4 m)(145.1 m)(132.2 m)(129.5 m)(77.2 m)(73.2 m)(65.7 m)

Total Equity

619.7 m623.9 m663.5 m675.4 m691.7 m651.7 m707.9 m722.8 m698.7 m

Financial Leverage

2 x2 x2 x1.9 x1.8 x2.4 x2.3 x2.3 x2.2 x
USDFY, 2013FY, 2014FY, 2015FY, 2016

Net Income

7 m(17.5 m)65.3 m35.4 m

Depreciation and Amortization

63.1 m65.8 m65.9 m42 m

Accounts Receivable

(17 m)(18 m)(9.5 m)(33.3 m)

Inventories

(3.6 m)(5.2 m)1.2 m(22.6 m)

Cash From Operating Activities

97.4 m115.5 m88.7 m156.3 m

Purchases of PP&E

(47.6 m)(58.4 m)(75.8 m)(88.4 m)

Cash From Investing Activities

(64.6 m)(104.8 m)(7.5 m)(304.9 m)

Long-term Borrowings

(74.3 m)

Cash From Financing Activities

(52.5 m)30.3 m(30.3 m)110.8 m

Interest Paid

12 m11.1 m11.1 m13.2 m

Income Taxes Paid

3.2 m13.6 m36.3 m23.7 m
USDQ2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017

Net Income

31.4 m41.4 m54.2 m(9.3 m)26 m29.5 m12.3 m

Depreciation and Amortization

16.1 m32.6 m49 m21.2 m46.3 m73.8 m29.5 m

Accounts Receivable

5.9 m637 k2.2 m6.9 m(8.6 m)(3 m)924 k

Inventories

157.4 m159.7 m(11.4 m)(15.2 m)(19.8 m)(9.4 m)(12 m)(22.4 m)(13.6 m)

Cash From Operating Activities

26 m35.2 m48 m57.4 m100.2 m96 m28 m

Purchases of PP&E

(30.7 m)(48 m)(59.9 m)(18.3 m)(52.6 m)(73.9 m)(34.5 m)

Cash From Investing Activities

(57.4 m)(72.1 m)(19.3 m)(190.7 m)(236.3 m)(290 m)(38.3 m)

Cash From Financing Activities

(22 m)(26.3 m)(29 m)210.4 m206.1 m204.5 m(10.1 m)

Income Taxes Paid

(13.7 m)(38.7 m)(52.7 m)9.4 m10.5 m6.8 m(1.3 m)
USDY, 2017

Revenue/Employee

113.6 k

Financial Leverage

2.2 x

NuVasive Market Value History

NuVasive Median Salaries

Source: 31 public H-1B filings from NuVasive

Traffic Overview of NuVasive

NuVasive Online and Social Media Presence

NuVasive Company Life and Culture

You may also be interested in